Last reviewed · How we verify
Antria Cell Preparation Process
At a glance
| Generic name | Antria Cell Preparation Process |
|---|---|
| Also known as | SVF |
| Sponsor | Antria |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Stromal Vascular Fraction From Lipoaspirate to Treatment of Chronic Non-healing Wound (PHASE1)
- Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells (PHASE1)
- Extraction of Stromal Vascular Fraction and Stem Cells From Fat Tissue (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antria Cell Preparation Process CI brief — competitive landscape report
- Antria Cell Preparation Process updates RSS · CI watch RSS
- Antria portfolio CI